COFINIMMO
Cofinimmo has a 40-year history of acquiring, developing, and managing rental properties across Europe. Its portfolio is valued at approximately 6.2 billion EUR, with a focus on high-quality care, living, and working spaces. The companys mission is to provide these spaces that directly benefit occupants. Cofinimmo has built a healthcare real estate portfolio of 4.7 billion EUR in Europe. It has around 155 employees across five offices and is listed on Euronext Brussels (BEL20). The company benefits from the REIT system in Belgium, France, and the Netherlands. Its activities are supervised by the Financial Services and Markets Authority (FSMA), the Belgian regulator.
Overview
Strengths
- Shows the financial signature of a durable competitive advantage (economic moat): an asset-light, cash-generative model, high, stable gross margins (pricing power) and operating margins that held up every year.
- Pricing power: gross margin has held between 74% and 76% over the last 6 years (latest 75.6%).
- Asset-light, cash-generative model: capital expenditure takes only 0.3% of revenue and free cash flow was positive in each of the last 6 years.
- Valued below its Real Estate peers: P/FCF 10.6x vs. a median of 14.5x.
- Skin in the game: insiders own 80% of the shares, aligning management with shareholders.
- Cheaper than its own history: P/E 14.8x vs. a historical average of 33.6x and P/FCF 10.6x vs. a historical average of 14.4x.
Weaknesses
- No sign of a competitive advantage: return on invested capital (latest 5.9%) has been below its cost of capital of 6.8% in each of the last 6 years.
- High leverage: net debt is 5.3x EBITDA, against a median of 6.1x for its Real Estate peers.
- Our discounted cash flow target price (34.54 EUR) is 58% below the current price.
- Shareholder dilution: the share count has grown by 5.1% a year over the last three years.
- Tight liquidity: current liabilities exceed current assets (current ratio 0.09).
Key Financial Data